VITA Receives FDA Clearance for VITOMATRIX (VITA) Orthovita (VITA 2.10 +0.09) announced the FDA has cleared VITOMATRIX Bone Graft Substitute as a bone grafting material in certain dental procedures. It is estimated 375K procedures are performed domestically each year where VITOMATRIX can be used